10/02/2026
Day 2 of the assessment at the Drug Management Agency focused on strengthening systems and building a more resilient state health supply chain (SHSS). The discussions highlighted DMA’s growing role in ensuring medicine availability, supporting Universal Health Coverage, and improving efficiency across the health system.
The engagement emphasized that strong supply chains are built on sound planning, collaboration, and accountability - not just transactions. A resilient state supply chain remains critical to delivering quality healthcare and achieving sustainable health outcomes.
Grateful to the NPSCMP, ARC ESM team and all stakeholders for the valuable insights and shared commitment to health system strengthening.
We specially appreciate Global Fund for the sponsorship and the impactful support toward strengthening health supply chain systems.